Alzheimer’s drug, the monoclonal antibody lecanemab, slowed decline in a phase 3 clinical trial, the company said.
admin, , HEALTH & FITNESS, 0
feel free to call us +646-389-3981 [email protected]
Alzheimer’s drug, the monoclonal antibody lecanemab, slowed decline in a phase 3 clinical trial, the company said.
April 21-27 is National Infertility Awareness Week. All week, TODAY will be sharing stories to raise awareness of what...
The United States had administered 309,322,545 doses of Covid-19 vaccines and distributed 374,398,105 doses in the country as of...
The Centers for Disease Control and Prevention is warning gay and bisexual men in Florida about an outbreak of...
The number of children with lead poisoning potentially linked to tainted pouches of cinnamon apple puree and cinnamon applesauce...
As many as 3 million Americans received a Covid-19 vaccine booster shot in the past three days, the White...
President Donald Trump’s physician said Wednesday that the president has Covid-19 antibodies, though experts say it’s unclear what this...
WASHINGTON — President Joe Biden has agreed to meet a group of 10 Republican senators who have proposed a...
Johnson & Johnson’s Covid-19 vaccine began shipping out Monday morning, and Americans should begin getting the single-dose shot within...